Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06144515 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Dec 31, 2025 → Dec 31, 2027
See other at-risk trials from Minovia Therapeutics Ltd.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2025 to Dec 31, 2027
    • Study completion pushed from Mar 1, 2026 to Mar 1, 2028
    • Eligibility criteria expanded, about 3 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Dec 1, 2025 to Dec 31, 2025
    • Study completion date: Dec 1, 2025 to Mar 1, 2026
    • Site details revised
    v4
  3. Primary completion date: Feb 9, 2025 to Dec 1, 2025
    • Site details revised
    v3
  4. Primary endpoints: 8 to 3v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study Objective is to collect samples of bone marrow aspirates and peripheral blood of patients with MDS for use in non-clinical research to investigate mitochondrial function sequence and effect of mitochondrial augmentation.
Trial Details
NCT Number NCT06144515
Lead Sponsor Minovia Therapeutics Ltd.
Conditions
(from sponsor)		 Myelodysplastic Syndromes
Related terms Myelodysplastic Syndromes
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov